Review



c affymetrix hg u133a rna microarray dataset  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Thermo Fisher c affymetrix hg u133a rna microarray dataset
    Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix <t>HG-U133A</t> RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001
    C Affymetrix Hg U133a Rna Microarray Dataset, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+affymetrix+hg+u133a+rna+microarray+dataset/pmc08953143-143-0-1
    Average 86 stars, based on 1 article reviews
    c affymetrix hg u133a rna microarray dataset - by Bioz Stars, 2026-10
    86/100 stars

    Images

    1) Product Images from "Pan-cancer analysis identifies BIRC5 as a prognostic biomarker"

    Article Title: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

    Journal: BMC Cancer

    doi: 10.1186/s12885-022-09371-0

    Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001
    Figure Legend Snippet: Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001

    Techniques Used: Expressing, Microarray

    Related Articles

    Microarray:

    Article Title: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker
    Article Snippet: .. C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. ..



    Similar Products

    c affymetrix hg u133a rna microarray dataset  (Thermo Fisher)
    86
    Thermo Fisher c affymetrix hg u133a rna microarray dataset
    Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix <t>HG-U133A</t> RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001
    C Affymetrix Hg U133a Rna Microarray Dataset, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/c+affymetrix+hg+u133a+rna+microarray+dataset/pmc08953143-143-0-1
    Average 86 stars, based on 1 article reviews
    c affymetrix hg u133a rna microarray dataset - by Bioz Stars, 2026-10
    86/100 stars
    		  Buy from Supplier

    Image Search Results


    Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001

    Journal: BMC Cancer

    Article Title: Pan-cancer analysis identifies BIRC5 as a prognostic biomarker

    doi: 10.1186/s12885-022-09371-0

    Figure Lengend Snippet: Box plots showing BIRC5 expression in ( A ) 16 different TCGA cancer types, ( B ) breast cancer compared to corresponding normal tissue. BIRC5 expression is significantly higher in all of the analyzed cancer types than normal tissue. C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types. BIRC5 expression is significantly higher in the majority of the analyzed cancer types than normal tissue. The Wilcoxon test was used to calculate statistically significant (Benjamini-Hochberg adjusted p -values) differences in BIRC5 expression between cancer and normal tissue. ns = not significant ( P > 0.05); * P ≤ 0.05; ** P ≤ 0.01; *** P ≤ 0.001; **** P ≤ 0.0001

    Article Snippet: C Affymetrix HG-U133A RNA microarray dataset with 21 cancer types, and ( D ) Affymetrix HG-U133 Plus 2 RNA microarray dataset comprised of 25 cancer types.

    Techniques: Expressing, Microarray